Market revenue in 2023 | USD 126.5 million |
Market revenue in 2030 | USD 315.5 million |
Growth rate | 14% (CAGR from 2023 to 2030) |
Largest segment | Software & services |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Software & Services |
Key market players worldwide | BioMerieux SA, Becton Dickinson & Co, Bruker Corp, Danaher Corp, Qiagen NV, Charles River Laboratories International Inc, Limerston Capital, Avantor Inc, Shimadzu Corp, Merck KGaA, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial identification market will help companies and investors design strategic landscapes.
Software & services was the largest segment with a revenue share of 37.79% in 2023. Horizon Databook has segmented the Canada microbial identification market based on instruments, consumables, software & services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada microbial identification market , including forecasts for subscribers. This country databook contains high-level insights into Canada microbial identification market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account